Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/b9292ba4-f8ac-4a1d-8792-aa3034145d5e/

PLYX

Polaryx Therapeutics, Inc. Common Stock
Chart
$2.33
Latest Week 2026-06-05
HealthcareBiotechnologyMICRO
Snapshot 2026-06-07 · 0.0w · Fresh
0.35
OS Score
42.0%
Value
41.0%
Quality
42.0%
Momentum
3/9
F-Score
0.415
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
0 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
42.0%ile
P/B
44.2×
FCF Yield
-0.050
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
58.00000000
/100 — 1=cheapest
VC2 (Trending Value)
58.00000000
/100
VC3 (Buyback)
58.00000000
/100
Negative FCF yield (-5.0%) — the business is currently cash-consumptive.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
41.0%ile
ROE
-2.603
ROA
-1.850
D/E
0.41
Current
3.45
F-Score
3/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Stability
0.826
lower=better
Accruals
-0.337
lower=better
5yr Consist
No
Conservative balance sheet with D/E of 0.41.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
42.0%ile
Vol 252d
287.2%
Vol 60d
166.8%
↓ Contracting
Max DD 12M
-70.1%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
Volatility is compressing — 60d (167%) well below 252d (287%).
OS
Composite & Factor Heatmap
All factors at a glance
0.35
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 500 peers
Sector Value %ile
10.0%
Sector Quality %ile
10.2%
P/B z-score
3.26
Sector Avg OS
63.3%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
IRWD Ironwood Pharmaceuticals Inc 99.0% 93.0% 86.0% 98.0%
RIGL Rigel Pharmaceuticals Inc 98.0% 94.0% 92.0% 76.0%
FBIO Fortress Biotech Inc 98.0% 97.0% 93.0% 74.0%
WW WW International, Inc. Common Stock 97.0% 88.0% 80.0% 99.0%
PBYI Puma Biotechnology Inc 97.0% 80.0% 97.0% 92.0%
CGEN Compugen 97.0% 90.0% 95.0% 76.0%
FBIOP Fortress Biotech Inc Pref Series A 97.0% 81.0% 95.0% 90.0%
MD Mednax Inc 96.0% 87.0% 80.0% 87.0%
Factor Interactions
Volatility Compressing
60-day vol (167%) well below 252-day (287%). Price action is stabilising.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
3.7% avg (3 factors)
Quality
C
58.0% avg (5 factors)
Risk
F
0.0% avg (1 factors)
Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.350—0—
Value %ile0.420—0—
Quality %ile0.410—0—
Momentum %ile0.420—0—
F-Score3.000—1—
Confidence0.545—0—
Volatility2.872—1—
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
Price / Book
44.22
FCF Yield
-5.0%
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
-260.3%
Return on Assets
-185.0%
Debt / Equity
0.41
Current Ratio
3.45
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.337
MomentumPrice trend strength over different horizons
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Earnings Stability (CV)
Lower = more stable
0.826
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
3
Dividend Yield
0.0%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
58
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
58
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
58
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity